Author

Matt R. Teater

Weill Cornell MedicineORCID 0000-0001-9415-1659Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell-cell communication· 1 Assay:ChIP-seq· 1

Frequent Co-Authors

Ari M. MelnickiD· 2 shared Abdelillah MaaradiD· 1 shared Alexandra E. KovachiD· 1 shared Amy ChadburniD· 1 shared Ana Carolina Bastos Sant'Anna SilvaiD· 1 shared Arnaud JacqueliD· 1 shared Bhavneet Binder· 1 shared Calixte CalaudiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Ari M. MelnickORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyBlood Cancer JournalPeer-reviewedApr 22, 2026

Transcriptome sequencing of Hodgkin lymphoma Hodgkin and Reed-Sternberg cells reveals escape from NK cell recognition and an unfolded protein response

Mikhail Roshal, Isabella Y. Kong, Wikum Dinalankara…·Ethel Cesarman

This study identifies unique transcriptional features of Hodgkin lymphoma HRS cells, including immune evasion mechanisms and an unfolded protein response, distinguishing them from other B-cell lymphomas.

1 citation

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologyBlood NeoplasiaPeer-reviewedMar 2, 2026

Enhanced efficacy of a specific HDAC3 inhibitor in combination with 5-Azacitidine against diffuse large B-cell lymphoma

Calixte Calaud, Emilio M. Serrano-López, Leonie A. Cluse…·Pilar M. Domínguez

This study shows that combining a HDAC3 inhibitor with 5-Azacitidine enhances anti-tumor effects against DLBCL in vitro and in vivo, with reduced toxicity compared to single agents.

DOI 10.1016/j.bneo.2026.100214

humanDNA methylation

𝕏 PostBluesky